Your browser doesn't support javascript.
loading
Electronic nicotine delivery systems (ENDS): Frequency of use and smoking-cessation efforts among U.S. women of reproductive age.
Coleman, Sulamunn R M; Bunn, Janice Y; Klemperer, Elias M; Feinstein, Marc Jerome P; Higgins, Stephen T.
Afiliação
  • Coleman SRM; Vermont Center on Behavior and Health, University of Vermont, USA; Department of Psychiatry, University of Vermont, USA. Electronic address: sulamunn.coleman@uvm.edu.
  • Bunn JY; Vermont Center on Behavior and Health, University of Vermont, USA; Department of Medical Biostatistics, University of Vermont, USA.
  • Klemperer EM; Vermont Center on Behavior and Health, University of Vermont, USA; Department of Psychiatry, University of Vermont, USA.
  • Feinstein MJP; Vermont Center on Behavior and Health, University of Vermont, USA; Department of Psychiatry, University of Vermont, USA.
  • Higgins ST; Vermont Center on Behavior and Health, University of Vermont, USA; Department of Psychiatry, University of Vermont, USA; Department of Psychological Science, University of Vermont, USA.
Prev Med ; : 108020, 2024 May 29.
Article em En | MEDLINE | ID: mdl-38821421
ABSTRACT

OBJECTIVE:

Reducing harm from combustible cigarette use among women of reproductive age (WRA) is critical given their potential vulnerability to multigenerational adverse impacts of cigarette smoking. Although electronic nicotine delivery systems (ENDS) are not approved smoking cessation aids in the US, many WRA who smoke report using ENDS to help quit smoking. Associations between ENDS use patterns and smoking-cessation efforts among US WRA remain unclear.

METHODS:

Using the Population Assessment of Tobacco and Health (PATH) Study, we examined whether baseline (Wave 3 or 4) ENDS use frequency predicted (a) making a cigarette quit attempt (QA) and (b) successful quitting by follow-up (Wave 4 or 5, respectively) among WRA (N = 2834; 72.1% non-Hispanic White).

RESULTS:

Daily ENDS use predicted greater adjusted odds of making a QA than non-daily (AOR = 1.63, 95% CI = 1.03, 2.59) and no ENDS use (AOR = 1.97, 95% CI = 1.23, 3.14), and greater odds of successful smoking cessation than non-daily use (AOR = 2.37, 95% CI = 1.31, 4.26). Daily ENDS use did not significantly improve odds of successful smoking cessation compared to no ENDS use (AOR = 1.62, 95% CI = 0.97, 2.69). Non-daily ENDS use did not significantly improve odds of making a QA (AOR = 1.21, 95% CI = 0.94, 1.56) and hindered successful smoking cessation compared to no ENDS use (AOR = 0.68, 95% CI = 0.48, 0.98).

CONCLUSIONS:

These findings suggest that benefits of ENDS for smoking cessation in WRA may be greatest among those who use ENDS daily. WRA who choose to use ENDS to help quit would be well-informed by evidence that non-daily ENDS use may impede smoking cessation.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Prev Med Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Prev Med Ano de publicação: 2024 Tipo de documento: Article